scholarly journals Pulmonary arteriovenous fistulas in patients with left isomerism and cardiac malformations

1998 ◽  
Vol 8 (3) ◽  
pp. 283-284 ◽  
Author(s):  
A. Amodeo ◽  
Bruno Marino
1998 ◽  
Vol 8 (3) ◽  
pp. 290-294 ◽  
Author(s):  
Hiroaki Kawata ◽  
Hidefumi Kishimoto ◽  
Seiichiro Ikawa ◽  
Takayoshi Ueno ◽  
Tohru Nakajima ◽  
...  

AbstractAbstract Hepatic venous blood has been thought to play some role as a vasoactive agent in the development of pulmonary arteriovenous fistulas in patients with congenital heart disease. During the last 15 years, we have observed pulmonary arteriovenous fistulas in 3, and systemic arteriovenous fistulas in 2, patients from our 16 cases of left isomerism. During the same period, neither pulmonary nor systemic arteriovenous fistulas were detected among 50 patients with right isomerism. Pulmonary arteriovenous fistulas had developed in the absence of surgery in 1 of the patients. Both pulmonary and systemic fistulas were detected in an another patient, in whom the hepatic venous blood bypassed the pulmonary circulation. The level of somatostatin, which is known to reduce splanchnic blood flow, was high in the systemic venous blood of this patient. Although the mechanism of development of the fistulas has yet to be clarified, we should be aware that not only pulmonary, but also systemic arteriovenous fistulas can be found in patients with left isomerism, even prior to any surgical intervention.


1956 ◽  
Vol 31 (3) ◽  
pp. 286-297
Author(s):  
Thomas J.E. O'Neill ◽  
Herbert Fisher ◽  
Donald E. McDowell ◽  
Vincent W. Lauby

Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Karan Topiwala ◽  
Smit Patel ◽  
Mubashir Pervez ◽  
Claire Shovlin ◽  
Mark J Alberts

Introduction: Pulmonary-arteriovenous-fistulas (PAVFs) are pathologic right-to-left shunts resulting in paradoxical embolism causing acute-ischemic-stroke (AIS). Recent single-center studies have identified that in patients with AIS associated with PAVF (AIS-P), traditional stroke risk-factors are not prominent and instead stroke-risk is associated with low serum iron. Single-centre studies have the risk of introducing a selection bias, while multicentre trials are challenging since PAVF still remains a rare and under-recognised entity. We thus seek epidemiological validation of such stroke predictors in patients with PAVF. Methods: We conducted a retrospective analysis of all AIS-admissions within the Nationwide-Inpatient-Sample (NIS) database (2005-2014). Baseline characteristics were compared across AIS populations [AIS-P (with PAVF) and R(routine)-AIS (without PAVF)]. We also compared morbidity, mortality and management trends of AIS in patients with and without PAVF. Results: Of 4,271,910 patients admitted with AIS, 822 (0.02%) were diagnosed with a PAVF. Over this decade the prevalence of PAVF per million AIS-admissions, rose from 197 to 368 (P trend =0.026). Patients with PAVF were younger with a median age (IQR) of 57.5 (42.2 -70.4) years vs. 72.5 (60.8-82.1) years (p<0.001); but had comparable age-adjusted inpatient morbidity (χ 2 p=0.71) and all-cause mortality (χ 2 p=0.26). On multivariate analyses, the odds ratios (95% confidence-interval) favouring PAVF as the cause for AIS were 9.0 (6.79-11.94) for hypoxemia, 4.64 (3.84-5.60) for patent-foramen-ovale, 4.52 (3.42-5.97) for pulmonary hypertension, 4.07(2.23-7.44) for epistaxis, and 2.12 (1.60-2.82) for iron deficiency anaemia [all p-values <0.001]. Conclusion: Pulmonary-arteriovenous-fistula related AIS represents a significantly younger demographic, which suffers inpatient morbidity and mortality comparable to routine ischemic-stroke. They carry a unique set of stroke-risk markers, including treatable conditions such as iron deficiency anemia. Further studies are needed to examine a causal role for such markers on ischemic-stroke risk in this cohort.


Stroke ◽  
2019 ◽  
Vol 50 (Suppl_1) ◽  
Author(s):  
Karan Topiwala ◽  
Smit Patel ◽  
Karan Tarasaria ◽  
Mubashir Pervez

2009 ◽  
Vol 57 (7) ◽  
pp. 385-388 ◽  
Author(s):  
Makoto Takahama ◽  
Ryoji Yamamoto ◽  
Ryu Nakajima ◽  
Nobuhiro Izumi ◽  
Hirohito Tada

Sign in / Sign up

Export Citation Format

Share Document